CHD Chemicals Limited has announced a Board of Directors meeting scheduled for February 14, 2026, to review and approve its quarterly financial performance. The meeting represents a key milestone in the company's financial reporting calendar as it prepares to present its third-quarter results for the fiscal year 2026.

Meeting Details and Agenda

The Board meeting will be held on Saturday, February 14, 2026, at 1:00 PM at the company's corporate office located at Plot No. 331, Industrial Area, Phase II, Panchkula-134113. The primary agenda includes consideration and approval of audited financial results for the quarter and nine months ended December 31, 2025, along with the corresponding auditor's report.

Trading Window Restrictions

In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, CHD Chemicals Limited has implemented a trading window closure period. This restriction commenced on January 1, 2026, and will remain in effect until February 16, 2026, covering both dates inclusively.

The trading restrictions apply to:

• Directors of the company
• Key Managerial Personnel (KMP)
• Designated employees
• Immediate relatives of the above categories

Regulatory Compliance

The company has formally notified the Bombay Stock Exchange (BSE) about the upcoming Board meeting through an official communication dated February 6, 2026. CHD Chemicals Limited trades on BSE under the script code 539800, with CIN number L24232CH2012PLC034188. The notification was signed by Director Mehtab Singh, ensuring proper corporate governance and regulatory compliance.

Corporate Information

CHD Chemicals Limited operates from its corporate office in Panchkula's Industrial Area Phase II. The company maintains transparency in its financial reporting processes and adheres to all regulatory requirements for listed entities. The upcoming Board meeting demonstrates the company's commitment to timely disclosure of financial information to stakeholders and regulatory authorities.

CHD Chemicals Limited has officially notified the Bombay Stock Exchange regarding the resignation of its statutory auditor M/s DSP & Associates, effective January 30, 2026. The company submitted the requisite intimation under Regulation 30 of the Listing Regulations, ensuring compliance with SEBI guidelines for auditor changes.

Auditor Resignation Details

DSP & Associates, a chartered accountancy firm with registration number 006791N, formally tendered their resignation through a letter dated January 30, 2026. The resignation becomes effective immediately, following the completion of their statutory audit responsibilities for the quarter ended September 30, 2025.

Regulatory Compliance

The company has fulfilled its disclosure obligations pursuant to SEBI Circular No. CIR/CFD/CMD1/114/2019 dated October 18, 2019, and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. CHD Chemicals submitted comprehensive details about the auditor change to maintain transparency with stakeholders and regulatory authorities.

Auditor's Confirmation

In their resignation letter, DSP & Associates explicitly confirmed that no material disagreements existed with the company's management or audit committee during their tenure. The firm stated that there were no disputes regarding accounting principles, auditing practices, scope of audit, or financial disclosures. The auditing firm, based in Ludhiana with offices at City Tower, Model Town, cited professional commitments as the sole reason for their departure.

Corporate Governance Impact

The resignation letter was signed by Sidharth Gupta, Partner at DSP & Associates with membership number 541066. CHD Chemicals' Director Mehtab Singh digitally signed the notification to the stock exchange, ensuring proper authorization of the disclosure. The company will need to initiate the process of appointing a new statutory auditor to maintain compliance with corporate governance requirements and continue fulfilling its audit obligations for upcoming financial periods.